Clinical Trials

Showing trials with last updates posted in 2024.

NCT04526795 | TERMINATED | PHASE1
19 participants

Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-12
Start Date:
2021-04-09
Completion:
2024-11-15
Conditions
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Recurrent Acute Biphenotypic Leukemia
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Recurrent T-Cell Prolymphocytic Leukemia
  • Refractory Acute Biphenotypic Leukemia
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Acute Myeloid Leukemia
  • Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Refractory T-Cell Prolymphocytic Leukemia
Interventions
  • DRUG
No Results Yet
NCT04310592 | TERMINATED | PHASE1
27 participants

Natural Killer Cell (CYNK-001) Infusions in Adults with AML

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-12
Start Date:
2020-03-12
Completion:
2023-01-20
Conditions
  • Leukemia
  • Leukemia, Myeloid
  • Leukemia, Myeloid, Acute
  • Neoplasms by Histologic Type
  • Neoplasms
  • Immunosuppressive Agents
  • Immunologic Factors
  • Physiological Effects of Drugs
  • Alkylating Agents
  • Antimetabolites, Antineoplastic
  • Antiviral Agents
  • Analgesics, Non-narcotic
  • Anti-infective Agents
  • Analgesics
  • Peripheral Nervous System Agents
  • Hematologic Diseases
  • Hematologic Neoplasms
  • Leukemia in Remission
  • Relapsed Adult AML
  • Refractory AML
Interventions
  • BIOLOGICAL
No Results Yet
NCT04136275 | COMPLETED | PHASE1
6 participants

CAR-37 T Cells in Hematologic Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-12
Start Date:
2020-06-19
Completion:
2023-09-30
Conditions
  • Hematologic Malignancy
  • Leukemia
  • Lymphoma
  • Lymphoma, B-Cell
  • Lymphoma, T-Cell
  • Lymphoma, Non-Hodgkin
Interventions
  • BIOLOGICAL
No Results Yet
NCT04030325 | ACTIVE_NOT_RECRUITING | NA
1012 participants

Motivating Campus Change Study

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-12
Start Date:
2019-11-06
Completion:
2024-09-30
Conditions
  • Drinking Behavior
Interventions
  • BEHAVIORAL
No Results Yet
NCT03755518 | TERMINATED | PHASE3
38 participants

A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-12
Start Date:
2019-03-27
Completion:
2021-11-26
Conditions
  • Primary Myelofibrosis
  • Post-Polycythemia Vera Myelofibrosis
  • Myelofibrosis
  • Post-essential Thrombocythemia Myelofibrosis
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page